Anterior cerebral artery strokes occur in the territory of the anterior cerebral artery which involves the superior and medial part of the parietal lobe along with the midline of the frontal lobe. These are uncommon causes of ischemic infarctions, making up about 0.3%-4.4% of stroke cases in series reports. The clinical presentation of this stoke is variable as it depends on whether the anterior cerebral artery or one of its branches is involved.
August 01, 2022
Anterior cerebral artery (ACA) strokes
Mean arterial pressure (MAP)
Mean arterial pressure (MAP)
* MAP = DP + 1/3(SP – DP) or
* MAP = DP + 1/3(PP)
Where DP is the diastolic blood pressure, SP is the systolic blood pressure, and PP is the pulse pressure.
To perfuse vital organs requires the maintenance of a minimum MAP of 60 mmHg. If MAP drops below this point for an extended period, end-organ manifestations such as ischemia and infarction can occur. If the MAP drops significantly, blood will not be able to perfuse cerebral tissues, there will be a loss of consciousness, and neuronal death will quickly ensue.
Satyendra Dhar MD,
Posterior cerebral artery (PCA) strokes
The incidence of PCA strokes can be estimated between 5% to 10%.
Patients may present in a comatose state via ambulance or may walk to an emergency department without assistance. Patients with a PCA stroke may present with only a headache and mild visual changes such as vision loss, diplopia, inability to see half of the view, or difficulty reading perceiving colors, or recognizing familiar faces.
Satyendra Dhar MD,
Middle Cerebral Artery (MCA) territory CVA
The neurological deficit will depend on the extent of the infarct and hemispheric dominance, and include:
- contralateral hemiparesis
- contralateral hemisensory loss
- hemianopia
- aphasia: if the dominant hemisphere is involved; may be expressive in anterior MCA territory infarction, receptive in posterior MCA stroke, or global with extensive infarction
- neglect: non-dominant hemisphere.
ProBNP (pro B-type natriuretic peptide)
ProBNP (pro B-type natriuretic peptide) is secreted by cardiomyocytes in response to stretch and is quickly cleaved into 2 circulating fragments—the biologically active 32-amino acid C-terminal BNP (B-type natriuretic peptide) and the inert 76-amino acid NT-proBNP (N-terminal pro-BNP). Both fragments are routinely used to aid diagnosis of heart failure, predict outcomes, and to monitor the effects of therapy.
Differences between BNP and NT-proBNP on a biological level
really relate to the fact that one is biologically active as a hormone, BNP,
whereas NT-proBNP is cleared passively from the body and is not biologically
active.
BNP has a much shorter half-life, and NT-proBNP has a longer
half-life. NT-proBNP, as a consequence, circulates in higher concentrations in
the bloodstream, therefore, more likely to be more sensitive for detecting
earlier forms of heart failure because it circulates at somewhat higher levels.
BNP and NT-proBNP are extracted by the kidneys to a
comparable extent of only about 15–20%. The calculated biological half-lives of
BNP range from 13 to 20 minutes and of NT-proBNP from 25 to 70 minutes.
BNP and NT-proBNP are cleared differentially: BNP is actively removed from the bloodstream (binding to clearance receptors and a much lesser extent by enzymatic degradation by neutral endopeptidase) and also has passive clearance mechanisms, including renal clearance; NT-proBNP is cleared more passively by organs with high rates of blood flow (e.g. muscle, liver, kidneys).
Satyendra Dhar MD,
Pancreatic pseudocysts
Pancreatic pseudocysts are fluid collections in the pancreatic tissue or the adjacent pancreatic space. It is surrounded by a well-defined wall and contains essentially no solid material. Most pancreatic pseudocysts occur as a consequence of acute pancreatitis. However, they can also occur in the setting of chronic pancreatitis, postoperatively, or after pancreatic trauma. Pseudocysts may be asymptomatic or may present with a variety of symptoms such as pain, satiety, upper gastrointestinal bleeding, nausea, and vomiting. The maturation period of pancreatic pseudocysts is reported to be approximately 2 to 6 weeks, and during this time, 33% of cysts are expected to spontaneously resolve. However, a substantial number of persistent cysts require treatment, owing to potential complications such as infection, hemorrhage, and cyst rupture.
Satyendra Dhar MD,
Circle of Willis and brain circulation
Circle of Willis and brain circulation
Herophilus of Chalcedon (335-280 BC), “Father of Anatomy,” described the vascular structure at the base of the brain which he named the rete mirabile (Latin for “wonderful net”). Although works of Herophilus were tragically destroyed on Julius Caesar’s invasion of Alexandria, some of his teaching can be found in the writings of Galen, who was said to have possessed all his work. Thomas Willis (1621–1675), a physician and Professor of Natural Philosophy at Oxford in the mid-17th century, demonstrated with great precision both the structure and the function of one major anastomotic arterial system. For this reason, the name of this structure is interchangeable, either as Willis’ circle or as Willis’ polygon, being one of the most famous eponymous structures in human anatomy. Hippocrates, “father of medicine” first recognized CVA > 2400 years ago & called it apoplexy, Greek term - "struck down by violence". Name described sudden changes occurring in stroke but didn’t necessarily convey what’s actually happening in the brain.
Satyendra Dhar MD,
C-REACTIVE PROTEIN
C-REACTIVE PROTEIN
Discovered by Tillett & Francis in 1930. First
identified as a substance in the serum with acute inflammation that reacted
with the "c" carbohydrate Ab of the capsule of pneumococcus.
CRP is a pentameric protein synthesized by the liver, whose level rises in response to inflammation. CRP is an acute-phase reactant protein that is primarily induced by the IL-6 action on the gene responsible for the transcription of CRP during the acute phase of an inflammatory/infectious process.
Lab values vary, and there is no standard at present. However, in general, the result is reported in either mg/dL or mg/L. Hs-CRP is usually reported in mg/L.
Interpretation of CRP levels:
- Less than 0.3 mg/L: Normal (level seen in most healthy adults).
- 0.3 to 1.0 mg/L: Normal or minor elevation (can be seen in obesity, pregnancy, depression, diabetes, common cold, gingivitis, periodontitis, sedentary lifestyle, cigarette smoking, and genetic polymorphisms).
- 1.0 to 10.0 mg/L: Moderate elevation (Systemic inflammation such as RA, SLE, or other autoimmune diseases, malignancies, myocardial infarction, pancreatitis, bronchitis).
- More than 10.0 mg/L: Marked elevation (Acute bacterial infections, viral infections, systemic vasculitis, major trauma).
- More than 50.0 mg/L: Severe elevation (Acute bacterial infections).
Certain medications, such as NSAIDs will falsely decrease
CRP levels. Statins, as well, have been known to reduce CRP levels falsely.
Recent injury or illness can falsely elevate levels, particularly when using
this test for cardiac risk stratification. Magnesium supplementation also can
decrease CRP levels.
As mentioned above, mild elevations in CRP can be seen without any systemic or inflammatory disease. Females and elderly patients have higher levels of CRP. Obesity, insomnia, depression, smoking, and diabetes can all contribute to mild elevations in CRP, and the results shall be interpreted with caution in individuals with these comorbidities.
Satyendra Dhar MD,